|
MERIDIAN BIOSCIEN, (VIVO) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
Meridian Bioscience, Inc., an integrated life science company, engages in the manufacture, distribution, and marketing of diagnostic test kits, purified reagents, and related products. It also offers biopharmaceutical enabling technologies. The company operates through three segments: The US Diagnostics, The European Diagnostics, and The Life Science. The US Diagnostics segment develops, manufactures, markets, and distributes diagnostic test kits, primarily for certain respiratory, gastrointestinal, viral, and parasitic infectious diseases. In addition to diagnostic test kits, products also include transport media that store and preserve specimen samples from patient collection to laboratory testing. The European Diagnostics segment markets and distributes diagnostic test kits manufactured by the US Diagnostics operating segment, and others manufactured by third party vendors in Europe, Africa, and the Middle East. The Life Science segment develops, manufactures, markets, and distributes bulk antigens and reagents used by researchers and other diagnostic companies, as well as the contract manufacturing of proteins and other biologicals used by biopharmaceutical and biotechnology companies. The company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, and diagnostics manufacturers. Meridian was formed in 1976 and is headquartered in Cincinnati, Ohio.
|
|
